ARCTURUS THERAPEUTICS HOLDINGS INC. Total Long-Term Debt
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) had Total Long-Term Debt of $13.30 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2022-11-09
- 2022-09-30: Long-term Debt $13.30M.
- 2022-06-30: Long-term Debt $15.30M.
- 2022-03-31: Long-term Debt $15.30M.
- 2021-12-31: Long-term Debt $15.30M.
| Period end | Long-term Debt |
|---|---|
| 2022-09-30 | $13.30M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $15.30M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $15.30M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $15.30M 10-K · filed 2022-03-01 |
| 2021-09-30 | $15.30M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $15.30M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $15.30M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $15.30M 10-K · filed 2021-03-01 |
| 2019-12-31 | $15.45M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |